Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance

Biometrical Journal

Volumn 49, Issue 4, 2007, Pages 613-626

  Lui, Kung Jong ^a   Chang, Kuang Chao ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Confounder; Mantel Haenszel estimator; Non compliance; Proportion ratio; Stratified randomized trial; Weighted least squares estimator

Indexed keywords

INTELLIGENT SYSTEMS; MEDICAL APPLICATIONS; SAMPLING;

CONFOUNDER; INTERVAL ESTIMATORS; MANTEL-HAENSZEL ESTIMATORS; NON-COMPLIANCE; OPTIMAL WEIGHT; PROPORTION RATIO; RANDOMIZED CLINICAL TRIALS; RANDOMIZED TRIAL; STRATIFIED RANDOMIZED TRIAL; WEIGHTED LEAST-SQUARES ESTIMATORS;

MONTE CARLO METHODS;

EID: 34548107687     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200510287     Document Type: Article

References (23)

1. Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996). Identification of causal effects using Instrumental variables. Journal of the American Statistical Association 91, 444-455.
2. Bernhard, G. and Compagnone, D. (1989). Binary data in prerandomized designs. Biometrical Journal 31, 29-33.
3. Brunner, E. and Neumann, N. (1985). On the mathematical basis of Zelen's prerandomized designs. Methods of Information in Medicine 24, 120-130.
4. Casella, G. and Berger, R. L. (1990). Statistical Inference. Duxbury, Belmont, California.
5. Cochran, W. G. (1977). Sampling Techniques. Wiley, New York.
6. Fleiss, J. L. (1981). Statistical Methods for Rates and Proportions. Wiley, New York.
7. Gillings, D. and Koch, G. (1991). The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Information Journal 25, 411-424.
8. Greenland, S. and Robins, J. M. (1985). Estimation of a common effect parameter from sparse follow-up data. Biometrics 41, 55-68.
9. Laupacis, A., Sackett, D. L., and Roberts, R. S. (1988). An assessment of clinically useful measures of the consequences of treatment. New England Journal of Medicine 318, 728-1733.
10. Lui, K. J. (2003). Interval estimation of treatment effects in double consent randomized design. Statistica Sinica 13, 179-187.
11. Lui, K. J. (2004). Statistical Estimation of Epidemiological Risk. Wiley, New York.
12. Lui, K. J. (2006). A Note on Hypothesis Test in Binary Data under the Single-Consent Randomized Design, Drug Information Journal 40, 219-227.
13. Mark, S. D. and Robins, J. M. (1993). A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial. Controlled Clinical Trials 14, 79-97.
14. Matsui, S. (2005), Stratified analysis in randomized trials with noncompliance. Biometrics 61, 816-823.
15. Matsuyama, Y. (2002). Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach. Statistics in Medicine 21, 675-687.
16. Multiple Risk Factor Intervention Trial Research Group (1982). Multiple risk factor intervention trial: Risk factor changes and mortality results. Journal of the American Medical Association 248, 1465-1477.
17. st edn). SAS Institute Inc.: Cary, North Carolina.
18. Sato, T. (1994). Randomized intend-to-treat analyses. Japanese Journal of Applied Statistics 23, 21-34 (in Japanese).
19. Sato, T. (2000). Sample size calculations with compliance information. Statistics in Medicine 19, 2689-2697.
20. Sato, T. (2001). A method for the analysis of repeated binary outcomes in randomized Clinical trials with noncompliance. Statistics in Medicine 20, 2761-2774.
21. Sheps, M. C. (1958). Shall we count the living or the dead? New England Journal of Medicine 259, 1210-1214.
22. Sheps, M. C. (1959). An examination of some methods of comparing several rates or proportions. Biometric 15, 87-97.
23. Sommer, A. and Zeger, S. L. (1991). On estimating efficacy from clinical trials. Statistics in Medicine 10, 45-52.